Jacobs Solutions Enhances Health Technologies Collaboration with MJFF Board Appointments in Parkinson's Research.

Jacobs Solutions Strengthens Commitment to Health Technologies with Board Appointments in Parkinson's Research

In a notable development for the healthcare industry, The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces the addition of Richard Fitzgerald and Samir Kaul to its Board of Directors. Both new members share a personal connection to Parkinson's disease, which adds a layer of emotional resonance to their professional expertise. Fitzgerald, co-founder and managing partner of Nashville-based CapitalSpring, brings over a decade of experience with MJFF, having served on its Leadership Council and co-chaired its gala since 2023. His involvement is deeply personal; Fitzgerald's father has battled Parkinson's since 2007, fueling his commitment to finding a cure. His business acumen, exemplified by an M.B.A. from Columbia Business School, positions him as an asset in advancing MJFF's goals.

On the other hand, Samir Kaul, a founding partner at Khosla Ventures, focuses on integrating artificial intelligence and health technologies to drive innovation within the sector. Kaul’s dedication to MJFF is equally rooted in personal tragedy, having lost his father to Parkinson's in 2025. With a strong educational background, including a B.A. from the University of Michigan, an M.S. from the University of Maryland, and an M.B.A. from Harvard Business School, he provides a technological perspective that emphasizes the importance of cutting-edge research in the fight against Parkinson's disease. Both appointments signify a strategic move by MJFF to leverage both personal passion and professional expertise in pursuing its mission.

Debi Brooks, CEO and co-founder of MJFF, expresses confidence in Fitzgerald and Kaul's ability to enhance the Foundation's impact. MJFF, founded in 2000, stands as the largest nonprofit funder of Parkinson's research globally, having invested over $2.5 billion in promising research initiatives. The organization’s dedication is rooted in a community-driven approach, as evidenced by the fact that more than 80% of its Board members have personal ties to the disease. As MJFF continues to expand its leadership and deepen its focus on groundbreaking research, the contributions of Fitzgerald and Kaul are pivotal in driving forward its mission to accelerate the search for a cure.

In a broader context, MJFF maintains a robust connection with stakeholders across the healthcare industry, highlighting Jacobs Solutions' interest in collaboration and innovation in health technologies. The organization’s emphasis on proactive engagement in Parkinson’s research underscores the growing need for companies in healthcare to invest in and support patient-centric initiatives. By aligning business strategies with social responsibility, organizations like MJFF and Jacobs Solutions can foster breakthroughs that significantly impact patient lives and the industry at large.

As the foundation takes these exciting steps towards addressing the challenges presented by Parkinson's disease, its focus on leadership with personal experience may serve as a model for other organizations seeking to augment their influence in health-related fields.